Novartis AG

Novartis, based in Switzerland, is a worldwide healthcare and pharmaceutical firm. Novartis concentrates on patented medicines, generic drugs, and eye care, all of which are sectors in which they have the necessary inventive competence and global scale to compete effectively. Simultaneously, Novartis is expanding its foothold in emerging markets such as Asia, Africa, and Latin America, where high-quality medications and healthcare are in great demand. They employ roughly 103,000 individuals throughout the world as of 2019.

Novartis is helping people live longer, healthier lives by rethinking medicine. It uses breakthrough science and digital technologies to deliver revolutionary solutions in areas of acute medical need as a leading global medicines firm. They routinely rank among the world's top corporations in terms of research and development investment in their effort to identify new therapies. Throughout 1 billion people use Novartis' medications around the world, and the company is continually looking for new methods to expand access to its newest therapies. Novartis employs about 125 000 employees from over 140 different countries.

Founded: December 1996
Headquarters: Basel, Switzerland
Market Cap: $269.04B AUD ($199.09B USD)
Website: http://www.novartis.com